Marketing to Infection Control Professionals

Why Infection Control Professionals Are a Critical Audience for Medical Device Companies

Infection control professionals (ICPs) occupy a unique and powerful position in healthcare purchasing decisions. These specialists, who include infection preventionists, hospital epidemiologists, and infection control nurses, influence which medical devices and products enter their facilities at a rate that far exceeds their relatively small numbers. When an ICP raises a concern about a device's infection risk or endorses a product's ability to reduce healthcare-associated infections (HAIs), the entire purchasing committee listens.

At Buzzbox Media, we help medical device companies in Nashville and nationally develop marketing strategies that speak directly to infection control professionals. This is an audience that demands rigorous evidence, values regulatory compliance, and approaches every product through the lens of patient safety. Generic device marketing will not work here. You need a specialized approach built on clinical data, regulatory awareness, and a deep understanding of what keeps these professionals up at night.

This guide covers everything you need to know about marketing medical devices to infection control professionals, from understanding their role and influence to developing content, messaging, and channel strategies that earn their trust.

Understanding the Infection Control Professional

Roles and Titles Within Infection Prevention

The infection control field encompasses several distinct roles, and your marketing needs to address each one appropriately. Infection preventionists (IPs) are the frontline professionals who implement surveillance programs, conduct audits, and develop protocols. They are often nurses with specialized certification, most commonly the Certification in Infection Prevention and Control (CIC) credential from the Certification Board of Infection Control and Epidemiology (CBIC).

Hospital epidemiologists are physicians, typically infectious disease specialists, who lead infection prevention programs and provide clinical oversight. They tend to be more engaged with research literature and clinical evidence. Environmental health and safety officers may also be involved in decisions related to surface disinfection, sterilization equipment, and waste management devices.

Understanding which role your device is most relevant to determines your messaging, your content format, and your distribution channels. An infection preventionist evaluating a hand hygiene monitoring system has different priorities than a hospital epidemiologist assessing a new rapid diagnostic for antimicrobial resistance.

The Influence ICPs Hold Over Purchasing Decisions

Infection control professionals have outsized influence on medical device purchasing for several reasons. First, regulatory bodies like the Centers for Medicare and Medicaid Services (CMS) and The Joint Commission require hospitals to maintain robust infection prevention programs. Devices that help meet these regulatory requirements receive strong ICP endorsement, which carries significant weight with hospital administrators.

Second, HAIs are enormously costly. The CDC estimates that HAIs affect approximately one in 31 hospital patients on any given day, and they cost the U.S. healthcare system tens of billions of dollars annually. Devices that demonstrably reduce HAI rates can generate substantial cost savings, making the ICP's recommendation a direct line to budget approval.

Third, ICPs often sit on or advise product evaluation committees, value analysis teams, and quality improvement councils. Their input can accelerate or halt a device purchase regardless of what other stakeholders think. Winning over the ICP is frequently the single most important step in selling infection-related devices to hospitals.

What Motivates Infection Control Professionals

ICPs are driven by a singular mission: protecting patients from preventable infections. Every decision they make, every product they evaluate, and every protocol they write is filtered through this lens. Your marketing must align with this mission authentically and specifically.

Beyond patient safety, ICPs are motivated by regulatory compliance, data quality, and operational efficiency. They need to track infection rates, report to state and federal agencies, and demonstrate continuous improvement. Devices that provide reliable data, automate surveillance, or streamline reporting processes are inherently attractive to this audience.

ICPs are also deeply connected to evidence-based practice. They follow guidelines from the CDC, the Society for Healthcare Epidemiology of America (SHEA), the Association for Professionals in Infection Control and Epidemiology (APIC), and the World Health Organization (WHO). Your device marketing must be grounded in these authoritative sources to be credible.

Building Your Value Proposition for Infection Control

Leading with Clinical Evidence

No audience in healthcare is more evidence-driven than infection control professionals. They will scrutinize your clinical data with a level of detail that would make many marketing teams uncomfortable. This is not an audience you can win over with slick visuals or aspirational messaging. You need robust, peer-reviewed evidence that demonstrates your device's efficacy in reducing infection risk.

The gold standard is a randomized controlled trial published in a respected infection control journal like Infection Control and Hospital Epidemiology (ICHE), the American Journal of Infection Control (AJIC), or the Journal of Hospital Infection. If you have this level of evidence, it should be the centerpiece of your marketing.

If your evidence base includes observational studies, quality improvement projects, or real-world evidence, present it transparently. ICPs can spot inflated claims or cherry-picked data immediately, and doing so will destroy your credibility with this audience. Be honest about the limitations of your evidence while clearly articulating the strengths.

For a comprehensive look at how clinical evidence fits into broader medical device marketing strategies, our medical device marketing guide provides foundational principles that apply across clinical audiences.

Connecting to HAI Reduction Metrics

Infection control professionals think in terms of standardized infection ratios (SIRs), central line-associated bloodstream infection (CLABSI) rates, catheter-associated urinary tract infection (CAUTI) rates, surgical site infection (SSI) rates, and Clostridioides difficile (C. diff) rates. Your marketing should speak this language fluently.

If your device can impact any of these metrics, quantify the expected reduction based on your clinical data. "Facilities using [device] experienced a 40% reduction in CLABSI rates" is the kind of specific, measurable claim that gets an ICP's attention. Vague claims like "reduces infection risk" are meaningless to this audience.

Also connect your device to the CMS Hospital-Acquired Condition (HAC) Reduction Program and value-based purchasing programs. Hospitals in the bottom quartile of HAI performance face financial penalties. If your device helps them avoid those penalties or improve their public reporting scores, that is a powerful value proposition that resonates with both ICPs and the hospital administrators who control budgets.

Addressing Regulatory and Compliance Alignment

Infection control is heavily regulated, and ICPs need to know that your device aligns with current guidelines and regulatory requirements. Your marketing materials should clearly reference the relevant CDC guidelines, CMS Conditions of Participation, Joint Commission standards, and any state-specific infection reporting requirements that your device helps address.

If your device has received EPA registration (for surface disinfection products), FDA clearance, or meets specific AAMI sterilization standards, highlight these credentials prominently. ICPs need to know that recommending your device will not create compliance issues for their organization.

Content Marketing for Infection Control Audiences

White Papers and Technical Documents

Infection control professionals are among the most receptive healthcare audiences for long-form technical content. Unlike other audiences where brevity is paramount, ICPs will read a 15-page white paper if it contains rigorous data, sound methodology, and relevant conclusions. This is an audience that values depth over brevity.

Your white papers should follow a scientific format: background, methods, results, discussion, and conclusions. Include confidence intervals, p-values, and sample sizes. Address potential confounders and limitations. This level of scientific rigor signals that you take your evidence seriously and respect the ICP's ability to evaluate it critically.

Case Studies from Real Healthcare Facilities

Case studies are particularly effective with ICPs because they demonstrate real-world implementation and outcomes. A case study showing how a 500-bed community hospital reduced its CAUTI rate by implementing your device provides tangible proof that your product works outside of controlled study conditions.

Include specific details: facility size, baseline infection rates, implementation timeline, challenges encountered, and measured outcomes over a defined period. ICPs want to assess whether the results are likely to be replicable in their own facility. The more specific and transparent the case study, the more credible it becomes.

Webinars and Virtual Education

ICPs are active participants in continuing education, and webinars are a highly effective channel for this audience. APIC, SHEA, and state APIC chapters regularly host educational webinars, and sponsoring or co-presenting these sessions puts your brand in front of a highly engaged audience.

The content must be educational, not promotional. A webinar titled "Emerging Strategies for Reducing SSIs in Orthopedic Surgery" that includes a discussion of your device as one component of a multimodal prevention bundle will perform far better than a webinar that is essentially a product demonstration. Partner with recognized infection control leaders to present, and ensure the content provides genuine continuing education value.

Guidelines Summaries and Implementation Toolkits

One of the most effective content formats for infection control audiences is a practical implementation toolkit. ICPs are constantly translating published guidelines into actionable protocols for their facilities. If you can provide tools that help them do this, such as audit checklists, implementation timelines, staff education materials, or policy templates, you become a valued resource rather than just a vendor.

These toolkits should reference and align with published guidelines but provide the practical scaffolding that guidelines often lack. For example, if your device is a hand hygiene monitoring system, create a toolkit that includes a pre-implementation assessment checklist, a staff communication plan template, a data dashboard guide, and benchmark targets. This positions your company as a partner in infection prevention rather than simply a product seller.

Digital Marketing Strategies for Infection Control

SEO for Infection Prevention Topics

Infection control professionals regularly search for clinical guidelines, implementation strategies, and evidence summaries online. A targeted healthcare SEO strategy that positions your content for infection prevention search terms can drive highly qualified traffic to your website.

Focus on long-tail keywords that reflect how ICPs actually search: "CLABSI prevention bundle components," "UV-C disinfection evidence," "hand hygiene compliance monitoring systems," or "sterilization validation for flexible endoscopes." These specific, technical search terms indicate a searcher who is actively evaluating solutions and is much closer to a purchasing decision than someone searching for broad terms like "hospital infection prevention."

Email Marketing to Infection Control Lists

Targeted email campaigns to verified infection control professionals can be highly effective, but the content must meet the high standards this audience demands. Every email should provide genuine value: a new study summary, a guideline update, a practical tip, or access to a clinical resource. Promotional emails that lead with product features will be ignored or will prompt unsubscribes.

Build your email program around a cadence of educational content with occasional product-specific messages woven in naturally. A ratio of four educational emails to every one product-focused email is a good starting point. This builds trust and positions your company as a knowledge resource rather than a marketing machine.

Professional Association Channels

APIC and SHEA offer various marketing and sponsorship opportunities that provide access to their member audiences. APIC's annual conference (the APIC Annual Conference and International Meeting) is the premier event for infection preventionists, drawing thousands of attendees. Exhibiting, sponsoring educational sessions, or advertising in APIC's publications can provide direct access to your target audience.

SHEA's audience skews more toward hospital epidemiologists and physician leaders in infection control. Their annual conference, IDWeek (co-hosted with IDSA, HIVMA, and PIDS), and their publications (ICHE and Antimicrobial Stewardship and Healthcare Epidemiology) reach the clinical leaders who often drive device evaluation and adoption decisions.

Leveraging LinkedIn for Infection Control Networking

LinkedIn has become an increasingly important professional platform for infection control professionals. Many ICPs use LinkedIn to share research, discuss best practices, and network with peers. LinkedIn's targeting capabilities allow you to reach professionals by job title, certification, and organization, making it an effective platform for both organic content sharing and paid advertising.

Post thought leadership content that addresses current infection control challenges: antimicrobial resistance, emerging pathogens, environmental cleaning innovations, or new surveillance methodologies. Engage genuinely with ICP-authored content and participate in infection control-focused LinkedIn groups. This builds relationships and brand awareness over time.

Conference Marketing for Infection Control

APIC Annual Conference Strategy

The APIC Annual Conference is the single most important event for reaching infection preventionists. Your booth strategy should prioritize interactive demonstrations and evidence presentation over traditional exhibit hall marketing. ICPs want to see the data, try the product, and ask detailed technical questions. Staff your booth with clinical specialists who can discuss study methodology and outcomes, not just sales representatives who know the product features.

Pre-conference marketing is essential. Use targeted email campaigns, social media, and direct outreach to schedule booth meetings with key ICPs before the conference begins. The most productive conversations at APIC happen through pre-scheduled meetings, not walk-up traffic.

Satellite Symposia and Educational Sessions

Sponsoring or hosting satellite symposia at infection control conferences provides an extended opportunity to present evidence and engage with ICPs. These sessions typically run 60 to 90 minutes and allow for deeper exploration of clinical topics than a booth conversation permits.

Invite recognized infection control leaders to present alongside your clinical team. The presence of independent, respected voices lends credibility to your message. Ensure the content is educational and balanced, acknowledging the broader evidence landscape rather than presenting your product as the only solution.

Poster Presentations and Abstract Support

Supporting poster presentations at infection control conferences is a subtle but effective marketing strategy. Work with clinical partners to develop abstracts based on real-world outcomes data from facilities using your device. A poster presented by an independent infection preventionist describing their facility's experience with your product carries more credibility than any marketing collateral you could produce.

Provide data analysis support, poster design assistance, and conference registration sponsorship to make it easy for your clinical partners to share their results. These presentations generate peer-to-peer conversations that are far more influential than vendor-driven marketing.

Sales Enablement for Infection Control Conversations

Preparing Your Sales Team for Evidence-Based Conversations

Selling to infection control professionals requires a fundamentally different sales approach than selling to surgeons or administrators. ICPs expect your sales representatives to be fluent in infection prevention science, not just product specifications. Your reps need to understand HAI definitions, surveillance methodologies, prevention bundle components, and current clinical guidelines.

Invest in clinical training for your sales team that goes beyond product knowledge. They should be able to discuss the latest CDC guideline updates, explain the difference between process measures and outcome measures, and articulate how your device fits into a facility's existing infection prevention program. An ICP will disengage immediately if they sense the rep lacks clinical understanding.

Building Relationships with Infection Control Champions

Identifying and cultivating relationships with ICPs who can become internal champions for your device is one of the most effective sales and marketing strategies. An ICP who is genuinely convinced of your product's value will advocate for it through internal committees, present evidence to administrators, and influence their peers at professional conferences.

These relationships must be built on trust and mutual respect. Provide your champions with ongoing clinical updates, early access to new evidence, and opportunities to participate in research or quality improvement initiatives. Never pressure them to advocate beyond what they genuinely believe is warranted by the evidence.

Navigating the Value Analysis Process

In most hospitals, medical devices must pass through a value analysis committee before they can be purchased. ICPs often sit on these committees or provide recommendations to them. Your sales and marketing materials need to be tailored for the value analysis process, which evaluates clinical evidence, cost-effectiveness, operational impact, and vendor reliability.

Create a value analysis packet that includes: a clinical evidence summary, a cost-benefit analysis, an implementation plan, training requirements, vendor support details, and references from facilities of similar size and type. This comprehensive package makes it easier for your ICP champion to present a compelling case to the committee.

Product Categories and Messaging Considerations

Disinfection and Sterilization Devices

If your device falls into the disinfection or sterilization category, your marketing must address EPA registration status, kill claims, contact times, material compatibility, and user safety. ICPs evaluate these products with extreme precision, comparing kill claims across pathogens and assessing whether your product can be integrated into existing cleaning protocols.

Competitive positioning is particularly important in this category, as ICPs will directly compare your product to established alternatives. Provide clear comparison data and be transparent about where your product excels and where it has limitations. Honesty builds trust with this audience far more effectively than exaggerated claims.

Surveillance and Monitoring Technology

Surveillance technology, including hand hygiene monitoring systems, environmental monitoring devices, and infection tracking software, appeals directly to the ICP's core responsibilities. Marketing these products should emphasize data quality, reporting capabilities, integration with existing information systems, and actionable insights.

ICPs are often overwhelmed by data. Your messaging should focus not on the volume of data your system generates but on the actionable intelligence it provides. "Identifies CLABSI risk trends before infections occur" is far more compelling than "collects over 10,000 data points daily."

Barrier and Protective Devices

Devices in the barrier and protection category, such as antimicrobial dressings, catheter securement devices, closed-system transfer devices, and needleless connectors, require marketing that connects directly to HAI prevention bundles. ICPs evaluate these products based on how well they integrate into established prevention protocols and whether there is evidence supporting their impact on specific infection rates.

Position your product within the context of the relevant prevention bundle rather than as a standalone solution. For example, if your product is a chlorhexidine-impregnated dressing for central line sites, show how it fits into the CLABSI prevention bundle alongside hand hygiene, maximal sterile barrier precautions, and daily line necessity review. ICPs think in systems, and your marketing should reflect that systems-based approach.

Common Mistakes When Marketing to Infection Control Professionals

Making Claims Without Adequate Evidence

The fastest way to lose credibility with ICPs is to make clinical claims that are not supported by robust evidence. This audience reads the primary literature and will check your citations. If your claims are based on in-vitro studies but your marketing implies clinical efficacy, ICPs will notice and your brand reputation will suffer. Always match the strength of your claims to the strength of your evidence.

Ignoring the Multidisciplinary Nature of Infection Prevention

Infection prevention is inherently multidisciplinary, involving nursing, medicine, environmental services, perioperative teams, and administration. Marketing that focuses exclusively on the IP while ignoring other stakeholders misses the broader decision-making ecosystem. Create messaging and materials that address the concerns of each stakeholder group while maintaining the clinical rigor that ICPs demand.

Underestimating the Importance of Implementation Support

ICPs know from experience that the best device in the world is useless if it is poorly implemented. Your marketing must address implementation head-on: what does the rollout process look like, how long does training take, what support does your company provide during and after implementation, and what results can facilities expect at different stages of adoption. Failing to address these questions signals that your company does not understand the realities of infection prevention practice.

Using Fear-Based Marketing

While infections are serious and even deadly, fear-based marketing is counterproductive with this audience. ICPs deal with infection risk every day. They do not need to be frightened into action; they need to be equipped with better tools. Marketing that sensationalizes infection risk or uses scare tactics comes across as manipulative and unprofessional. Focus on evidence, solutions, and partnership instead.

Building Long-Term Relationships with the Infection Control Community

Marketing to infection control professionals is a long-term investment in credibility and trust. This is a tightly connected community where word spreads quickly, both positive and negative. A single ICP's negative experience with your company can influence dozens of peers through professional networks, conferences, and online communities.

The medical device companies that succeed with this audience are those that commit to genuine partnership. They fund independent research, support professional development, contribute to guideline development, and respond transparently when issues arise. They treat ICPs as partners in patient safety rather than targets for sales campaigns.

At Buzzbox Media in Nashville, we help medical device companies build these long-term relationships through evidence-based content, targeted digital strategies, and conference marketing programs designed specifically for the infection control community. The investment in getting this right pays dividends through sustained product adoption, strong clinical champions, and a reputation that opens doors across the healthcare system.